Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Laboratory Medicine

Official Journal of the German Society of Clinical Chemistry and Laboratory Medicine

Editor-in-Chief: Schuff-Werner, Peter

Ed. by Ahmad-Nejad, Parviz / Bidlingmaier, Martin / Bietenbeck, Andreas / Conrad, Karsten / Findeisen, Peter / Fraunberger, Peter / Ghebremedhin, Beniam / Holdenrieder, Stefan / Kiehntopf, Michael / Klein, Hanns-Georg / Kohse, Klaus P. / Kratzsch, Jürgen / Luppa, Peter B. / Meyer, Alexander von / Nebe, Carl Thomas / Orth, Matthias / Röhrig-Herzog, Gabriele / Sack, Ulrich / Steimer, Werner / Weber, Thomas / Wieland, Eberhard / Winter, Christof / Zettl, Uwe K.


IMPACT FACTOR 2018: 0.389

CiteScore 2018: 0.22

SCImago Journal Rank (SJR) 2018: 0.156
Source Normalized Impact per Paper (SNIP) 2018: 0.089

Online
ISSN
2567-9449
See all formats and pricing
More options …
Volume 38, Issue 5

Issues

Empfehlungen zur Häufigkeit der Anforderung von Laboruntersuchungen

Recommendations for the frequency of ordering laboratory testing

Matthias Orth
  • Corresponding author
  • Institut für Laboratoriumsmedizin, Vinzenz von Paul Kliniken gGmbH, Postfach 103163, 70199 Stuttgart, Deutschland
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Johannes Aufenanger / Georg Hoffmann / Walter Hofmann / Rupert Klosson / Ralf Lichtinghagen / Klaus-Martin Otte / Gudrun Stamminger / Yuriko Stiegler
  • Zentrum für Labormedizin und Mikrobiologie GmbH, Alfred Krupp Krankenhaus, Rüttenscheid, Essen
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Bernhard Wiegel
  • Institut für Laboratoriumsmedizin, Vinzenz von Paul Kliniken gGmbH, Postfach 103163, 70199 Stuttgart, Deutschland
  • Straubing, Deutschland
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Eberhard Wieland für die Sektion Labormanagement der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin
  • Institut für Laboratoriumsmedizin, Vinzenz von Paul Kliniken gGmbH, Postfach 103163, 70199 Stuttgart, Deutschland
  • Zentralinstitut für Klinische Chemie und Laboratoriumsmedizin, Klinikum Stuttgart, Stuttgart, Deutschland
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-10-08 | DOI: https://doi.org/10.1515/labmed-2014-0016

Zusammenfassung

Eine labormedizinische Diagnostik ist bei vielen Patienten für eine erfolgreiche medizinische Behandlung notwendig. Sowohl aus ökonomischen als auch aus ethischen Gründen sollten labormedizinische Leistungen weder zu häufig (als „Wiederholungsuntersuchungen“) noch zu selten angefordert werden. Mit diesen Empfehlungen werden für eine Reihe von labormedizinischen Untersuchungen anhand von Studien, pathophysiologischen Zusammenhängen und Konsensus Empfehlungen für eine sinnvolle Wiederholungsfrequenz gegeben. Diese Empfehlungen betreffen das minimale Zeitintervall zwischen 2 Messungen sowie die Kriterien zur Durchführung einer Wiederholungsbestimmung. Ergänzt werden diese Empfehlungen mit grundsätzlichen Überlegungen zur Indikation und Untersuchungsfrequenz von labormedizinischen Untersuchungen.

Abstract

Laboratory testing is crucial for the successful medical treatment of many patients. Laboratory tests should neither be ordered too infrequently nor too frequently (in the form of repeat testing). These recommendations summarize the intervals for repeat testing based on studies, pathophysiology and consensus, in regard to both the time intervals between two tests and the additional criteria for the repeat testing. These recommendations are complemented by general principles for the indication and testing frequency of laboratory testing.

Reviewed publication

WielandE.

Schlüsselwörter: Diagnostische Pfade; Untersuchungsfrequenz; Wiederholungsuntersuchungen

Keywords: diagnostic pathways; repeat testing; testing intervals

Literatur

  • 1.

    Rang M. The Ulysses syndrome. Can Med Assoc J 1972;106:122–3.PubMedGoogle Scholar

  • 2.

    Ciani O, Buyse M, Garside R, Pavey T, Stein K, Sterne JA, et al. Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study. BMJ 2013;346:f457.Google Scholar

  • 3.

    Houben PH, Winkens RA, van der Weijden T, Vossen RC, Naus AJ, Grol RP. Reasons for ordering laboratory tests and relationship with frequency of abnormal results. Scand J Prim Health Care 2010;28:18–23.CrossrefGoogle Scholar

  • 4.

    Plebani M. Evaluating laboratory diagnostic tests and translational research. Clin Chem Lab Med 2010;48:983–8.PubMedGoogle Scholar

  • 5.

    Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647–54.CrossrefGoogle Scholar

  • 6.

    Straseski JA, Lyon ME, Clarke W, Dubois JA, Phelan LA, Lyon AW. Investigating interferences of a whole-blood point-of-care creatinine analyzer: comparison to plasma enzymatic and definitive creatinine methods in an acute-care setting. Clin Chem 2011;57:1566–73.CrossrefGoogle Scholar

  • 7.

    Passerini R, Cassatella MC, Boveri S, Salvatici M, Radice D, Zorzino L, et al. The pitfalls of CA19-9: routine testing and comparison of two automated immunoassays in a reference oncology center. Am J Clin Pathol 2012;138:281–7.Google Scholar

  • 8.

    Driskell OJ, Holland D, Hanna FW, Jones PW, Pemberton RJ, Tran M, et al. Inappropriate requesting of glycated hemoglobin (Hb A1c) is widespread: assessment of prevalence, impact of national guidance, and practice-to-practice variability. Clin Chem 2012;58:906–15.PubMedCrossrefGoogle Scholar

  • 9.

    Cullen L, Mueller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013;62:1242–9.CrossrefGoogle Scholar

  • 10.

    Gregorakis AK, Stefanakis S, Malovrouvas D, Petraki K, Gourgiotis D, Scorilas A. Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy. Prostate 2008;68:759–65.PubMedCrossrefGoogle Scholar

  • 11.

    Loh TP, Tan KM, Saw S, Sethi SK. Glycated haemoglobin: what is the diagnostic yield at shortened testing intervals? Diabetes Res Clin Pract 2011;94:e40–2.CrossrefPubMedGoogle Scholar

  • 12.

    Oosterhuis WP. Gross overestimation of total allowable error based on biological variation. Clin Chem 2011;57:1334–6.CrossrefPubMedGoogle Scholar

  • 13.

    Orth M, Luley C. Circadian rhythms of lipoproteins. Clin Chem 1995;41:326–7.PubMedGoogle Scholar

  • 14.

    Hawkins R. Managing the pre- and post-analytical phases of the total testing process. Ann Lab Med 2012;32:5–16.PubMedCrossrefGoogle Scholar

  • 15.

    Wiwanitkit V. Types and frequency of preanalytical mistakes in the first Thai ISO 9002:1994 certified clinical laboratory, a 6-month monitoring. BMC Clin Pathol 2001;1:5.Google Scholar

  • 16.

    Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem 1997;43:1348–51.Google Scholar

  • 17.

    Carraro P, Zago T, Plebani M. Exploring the initial steps of the testing process: frequency and nature of pre-preanalytic errors. Clin Chem 2012;58:638–42.CrossrefPubMedGoogle Scholar

  • 18.

    Grecu DS, Vlad DC, Dumitrascu V. Quality indicators in the preanalytical phase of testing in a stat laboratory. Lab Med 2014;45:74–81.Google Scholar

  • 19.

    Pieroni L, Delanaye P, Boutten A, Bargnoux AS, Rozet E, Delatour V, et al. A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta 2011;412: 2070–5.Google Scholar

  • 20.

    Fraser CG, Petersen PH. Desirable standards for laboratory tests if they are to fulfill medical needs. Clin Chem 1993;39:1447–53; discussion 53-5.Google Scholar

  • 21.

    Tamimi W, Martin-Ballesteros J, Brearton S, Alenzi FQ, Hasanato R. Evaluation of biological specimen acceptability in a complex clinical laboratory before and after implementing automated grading serum indices. Br J Biomed Sci 2012;69:103–7.Google Scholar

  • 22.

    Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764–72.PubMedGoogle Scholar

  • 23.

    McDonald IG, Daly J, Jelinek VM, Panetta F, Gutman JM. Opening Pandora’s box: the unpredictability of reassurance by a normal test result. BMJ 1996;313:329–32.Google Scholar

  • 24.

    Zhi M, Ding EL, Theisen-Toupal J, Whelan J, Arnaout R. The landscape of inappropriate laboratory testing: a 15-year meta-analysis. PLoS One 2013;8:e78962.CrossrefGoogle Scholar

  • 25.

    Calderon-Margalit R, Mor-Yosef S, Mayer M, Adler B, Shapira SC. An administrative intervention to improve the utilization of laboratory tests within a university hospital. Int J Qual Health Care 2005;17:243–8.CrossrefGoogle Scholar

  • 26.

    Janssens PM, Wasser G. Managing laboratory test ordering through test frequency filtering. Clin Chem Lab Med 2013;51:1207–15.PubMedGoogle Scholar

  • 27.

    Aufenanger J, Schernikau E, Wieland E. The future role of laboratory medicine in hospitals. J Lab Med. 2011;34:271–6.Google Scholar

  • 28.

    Aufenanger J. Do diagnostic pathways contribute to economic improvement of a hospital? Considerations from the perspective of laboratory medicine. J Lab Med 2011:285–9.Google Scholar

  • 29.

    Wang TY, Serletti JM, Cuker A, McGrath J, Low DW, Kovach SJ, et al. Free tissue transfer in the hypercoagulable patient: a review of 58 flaps. Plast Reconstr Surg 2012;129:443–53.Google Scholar

  • 30.

    Neilson EG, Johnson KB, Rosenbloom ST, Dupont WD, Talbert D, Giuse DA, et al. The impact of peer management on test-ordering behavior. Ann Intern Med 2004;141:196–204.Google Scholar

  • 31.

    WHO. Delivering HIV test results and messages for re-testing and counselling in adults. Geneva: WHO, 2010:31.Google Scholar

  • 32.

    Kouri TT, Gant VA, Fogazzi GB, Hofmann W, Hallander HO, Guder WG. Towards European urinalysis guidelines. Introduction of a project under European Confederation of Laboratory Medicine. Clin Chim Acta 2000;297:305–11.Google Scholar

  • 33.

    Orth M, Rost I, Hoffmann GF, Klein H-G. Praktische Umsetzung des Gendiagnostikgesetzes (GenDG) in der Laboratoriumsmedizin, dem humangenetischen Laboratorium und der humangenetischen Beratung. J Lab Med 2011;35:243–53.Google Scholar

  • 34.

    Warner A, Privitera M, Bates D. Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry. Clin Chem 1998;44:1085–95.PubMedGoogle Scholar

  • 35.

    Zhu Y, Shennan M, Reynolds KK, Johnson NA, Herrnberger MR, Valdes R, Jr., et al. Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes. Clin Chem 2007;53:1199–205.Google Scholar

  • 36.

    Rentsch KM. Update zum Therapeutic Drug Monitoring und zu pharmakogenetischen Untersuchungen zur Optimierung der Therapie mit Psychopharmaka. J Lab Med 2014;38:63–74.Google Scholar

  • 37.

    Oellerich M, Armstrong VW, Kahan B, Shaw L, Holt DW, Yatscoff R, et al. Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 1995;17:642–54.CrossrefPubMedGoogle Scholar

  • 38.

    Sharma A, Salzmann M. The effect of automated test rejection on repeat requesting. J Clin Pathol 2007;60:954–5.PubMedGoogle Scholar

  • 39.

    Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med 2013;126:342–8.CrossrefPubMedGoogle Scholar

  • 40.

    Kwok J, Jones B. Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory. J Clin Pathol 2005;58:457–62.CrossrefGoogle Scholar

  • 41.

    Man A, Shojania K, Phoon C, Pal J, de Badyn MH, Pi D, et al. An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing. Clin Rheumatol 2013;32:601–8.CrossrefGoogle Scholar

  • 42.

    Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 2012;345:e5244.Google Scholar

  • 43.

    Diamandis EP, Hoffman BR, Sturgeon CM. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers. Clin Chem 2008;54:1935–9.CrossrefPubMedGoogle Scholar

  • 44.

    Bundesärztekammer (BäK), Kassenärztliche Bundesvereinigung (KBV), (AWMF) AdWMF. Nationale Versorgungsleitlinie Nierenerkrankungen bei Diabetes im Erwachsenenalter 2013; (1). Available at: http://www.diabetes.versorgungsleitlinien.de. Accessed on June 14 2014.

  • 45.

    Abujudeh HH, Gee MS, Kaewlai R. In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24 hours? J Am Coll Radiol 2009;6:268–73.CrossrefGoogle Scholar

  • 46.

    Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999;9:1602–13.CrossrefPubMedGoogle Scholar

  • 47.

    Purdy MA. Hepatitis B virus S gene escape mutants. Asian J Transfus Sci 2007;1:62–70.PubMedCrossrefGoogle Scholar

  • 48.

    Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, et al. Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology 2008;135:459–67.Google Scholar

  • 49.

    Harris KR, Dighe AS. Laboratory testing for viral hepatitis. Am J Clin Pathol 2002;118 Suppl:S18–25.Google Scholar

  • 50.

    Cornberg M, Protzer U, Petersen J, Wedemeyer H, Berg T, Jilg W, et al. Aktualisierung der S3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. Z Gastroenterol 2011;49:871–930.CrossrefGoogle Scholar

  • 51.

    Sarrazin C, Berg T, Ross RS, Schirmacher P, Wedemeyer H, Neumann U, et al. Update der S 3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion. Z Gastroenterol 2010;48:289–351.CrossrefGoogle Scholar

  • 52.

    Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G. Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 2008;31:971–3.PubMedCrossrefGoogle Scholar

  • 53.

    Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010;24:1121–7.PubMedCrossrefGoogle Scholar

  • 54.

    Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215–24.CrossrefGoogle Scholar

  • 55.

    Bianchi G, Kyle RA, Colby CL, Larson DR, Kumar S, Katzmann JA, et al. Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications. Blood 2010;116:2019–25; quiz 197.CrossrefGoogle Scholar

  • 56.

    International Myeloma Working G. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749–57.Google Scholar

  • 57.

    Weiner JP, Kfuri T, Chan K, Fowles JB. “e-Iatrogenesis”: the most critical unintended consequence of CPOE and other HIT. J Am Med Inform Assoc 2007;14:387–8.CrossrefGoogle Scholar

About the article

Korrespondenz: Priv.-Doz. Dr. med. Matthias Orth, Institut für Laboratoriumsmedizin, Vinzenz von Paul Kliniken gGmbH, Postfach 103163, 70199 Stuttgart, Deutschland, Tel.: +49 711 64892760, Fax: +49 711 64892688, E-Mail:


Received: 2014-08-15

Accepted: 2014-08-25

Published Online: 2014-10-08

Published in Print: 2014-10-01


Citation Information: LaboratoriumsMedizin, Volume 38, Issue 5, Pages 231–238, ISSN (Online) 1439-0477, ISSN (Print) 0342-3026, DOI: https://doi.org/10.1515/labmed-2014-0016.

Export Citation

©2014 by De Gruyter.Get Permission

Comments (0)

Please log in or register to comment.
Log in